Longevity Novo Nordisk’s Alzheimer’s GLP-1 gamble failsBy adminNovember 26, 20250 Long shot Phase 3 trial finds semaglutide did not deliver a statistically significant reduction in Alzheimer’s progression. Pharma giant Novo…
